The Imagion Biosystems Annual Report for the year ended 31 December 2018 is available here. Download the 2018 Annual Report.
Positive independent review sets priority path to market for MagSense® Technology
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance